Reduced dose and reduced exposure to non-vitamin K-antagonist oral anticoagulants: Some considerations on this relationship

被引：1
|
作者：
Rubboli, Andrea [1 ]
Verheugt, Freek W. A. [2 ]
机构：
[1] Osped Maggiore Bologna, Lab Intervent Cardiol, Div Cardiol, Largo Nigrisoli 2, I-40133 Bologna, Italy
[2] OLVG, Heartctr, Dept Cardiol, Oosterpk 9, NL-1091 AC Amsterdam, Netherlands
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 223卷
关键词：
Non-vitamin K-antagonist oral anticoagulants; Oral anticoagulation; ATRIAL-FIBRILLATION; RENAL-FUNCTION; WARFARIN; RIVAROXABAN; DABIGATRAN; APIXABAN; EFFICACY; SAFETY;
D O I：
10.1016/j.ijcard.2016.08.207
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：519 / 520
页数：2
相关论文
共 50 条
  • [1] Why the four non-vitamin K-antagonist oral anticoagulants are actually five
    Rubboli, Andrea
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 78 : 152 - 153
  • [2] Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes
    Rubboli, Andrea
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 : 22 - 28
  • [3] EFFECTIVENESS AND SAFETY OF REDUCED DOSE NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN PATIENTS WITHOUT SEVERE RENAL IMPAIRMENT
    Yao, X.
    Shah, N. D.
    Sangaralingham, L. R.
    Gersh, B. J.
    VALUE IN HEALTH, 2016, 19 (03) : A2 - A2
  • [4] Evaluation of indications for reduced-dose non-vitamin K antagonist oral anticoagulants in hospitalised patients with atrial fibrillation
    Jelonek, Olga
    Gorczyca, Iwona
    Baczek, Michal
    Kosmider, Pawel
    Wozakowska-Kaplon, Beata
    KARDIOLOGIA POLSKA, 2018, 76 (07) : 1073 - 1080
  • [5] Non-vitamin K antagonist oral anticoagulants and sport
    Romano, Silvio
    Salustri, Elisa
    Robles, Antonio G.
    Calo, Leonardo
    Penco, Maria
    Sciarra, Luigi
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (02): : 98 - 109
  • [6] Non-vitamin K antagonist oral anticoagulants (NOACs): clinical evidence and therapeutic considerations
    Saraf, Karan
    Morris, Paul
    Garg, Pankaj
    Sheridan, Paul
    Storey, Robert
    POSTGRADUATE MEDICAL JOURNAL, 2014, 90 (1067) : 520 - 528
  • [7] Adherence to and persistence with non-vitamin K-antagonist oral anticoagulants: does the number of pills per day matter?
    Rubboli, Andrea
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (10) : 1845 - 1847
  • [8] Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
    Malagu, Michele
    Longo, Filomena
    Marchini, Federico
    Sirugo, Paolo
    Capanni, Andrea
    Clo, Stefano
    Mari, Elisa
    Culcasi, Martina
    Bertini, Matteo
    BIOLOGY-BASEL, 2023, 12 (04):
  • [9] Non-vitamin K antagonist oral anticoagulants and heart failure
    Isnard, Richard
    Bauer, Fabrice
    Cohen-Solal, Alain
    Damy, Thibaud
    Donal, Erwan
    Galinier, Michel
    Hagege, Albert
    Jourdain, Patrick
    Leclercq, Christophe
    Sabatier, Remi
    Trochu, Jean-Noel
    Cohen, Ariel
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2016, 109 (11) : 641 - 650
  • [10] Reversal agents for non-vitamin K antagonist oral anticoagulants
    Levy, Jerrold H.
    Douketis, James
    Weitz, Jeffrey I.
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (05) : 273 - 281
12345